AMPH compared with KOP: revenue, margins and what each company keeps, and the suppliers and customers both name

AMPHAmphastar Pharmaceuticals, Inc.

Mkt capRevenueRevenue

KOPKoppers Holdings Inc.

Mkt capRevenueRevenue

Compare

AMPHAmphastar Pharmaceuticals, Inc.

KOPKoppers Holdings Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMPH

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±22.3%▲+4.90%×0.22

May 8 '26±13.2%▼−20.93%×1.58

Q1 FY26±15.6%▼−23.63%×1.51

Q3 FY25±14.4%▼−0.83%×0.06

KOP

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.9%▲+2.55%×0.28

May 8 '26±11.4%▲+6.88%×0.61

= impliedAMPH realized, solidKOP realized, hatchedOne scale, both sides: full bar = 24%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.4%

▲+7.88%

×0.59

Nov 7 '25±10.6%▼−4.09%×0.39

AMPHAmphastar Pharmaceuticals, Inc.

27.72▲+2.94%· post 27.72

Mkt cap$1.2BRevenue$184MQ2 FY26Revenue$720MFY25

KOPKoppers Holdings Inc.

41.27▼−1.42%· post 41.27

ClosedOct 30 '26

Mkt cap$784.8MRevenue$520MQ2 FY26Revenue$1.9BFY25

Compare

ClosedOct 30 '26

AMPHAmphastar Pharmaceuticals, Inc.

KOPKoppers Holdings Inc.

27.72▲+2.94%post 27.72

Price

41.27▼−1.42%post 41.27

$1.2B

Mkt cap

$784.8M

Q2 FY26$184M

Revenue

$520MQ2 FY26

FY25$720M

Revenue

$1.9BFY25

AMPH27.72▲+2.94%vsKOP41.27▼−1.42%ClosedOct 30 '26